CardioSignal wins Kasvu Open Award

CardioSignal has won the Kasvu Open award for the Growth Company of the Year. Kasvu Open, one of the biggest startup sparring and acceleration programs in Finland, chose the winners among 200 small and mid-sized companies.

Kasvu Open awards annually two companies in different size categories with a strong ambition for growth, a motivated team and proven market potential. In the Kasvu Open release, the judge panel chairman Lennu Keinänen highlighted the importance of tackling a current problem and having a scalable business model.  

“The entire CardioSignal team is honored to be recognized for our continued efforts to bring a novel heart health technology available to global markets. The direction and inspiration provided Kasvu Open has been valuable as we undergo rapid expansion and growth,” said CEO and cardiologist Juuso Blomster.

The awards ceremony was held in Kasvu Open carneval in Jyväskylä on November 3, 2022.

Further information
CEO Juuso Blomster, juuso.blomster@cardiosignal.com
Communications Director Juulia Simonen, juulia.simonen@cardiosignal.com. Tel +358503059018

About CardioSignal

We develop groundbreaking solutions for the detection of heart diseases with digital cardiac biomarkers. CardioSignal utilizes motion sensor technology to non-invasively measure cardiac motion and function. Originally an academic spinoff, the company’s patented technology is built on a decade of research and algorithm development. CardioSignal is a brand and a product by Precordior.

Photo: Kasvu Open. From left: Niina Suuriniemi Hopper (EVA Global), Juuso Blomster, Tuomas Valtonen (CardioSignal)

Previous
Previous

OMRON Healthcare announces partnership with CardioSignal to innovate early cardiovascular disease detection and remote patient monitoring at scale

Next
Next

CardioSignal and JISEKI Health advance health equity by introducing a new model in cardiac remote patient monitoring in the USA